![Pearls in a shell](/media/hbmpartners/styles/hero_small/public/images/hero-images/hero-portfolio-companies.jpg?h=14832055&itok=DIQpNLis)
Arrakis Therapeutics, USA
Industry
Oncology
Website
HBM contact
Company status
Private
Arrakis is pioneering the discovery of small-molecule medicines that directly bind to and modify the biological function of RNA to treat disease. This new class of medicines, RNA-targeted small molecules (rSMs), can unlock the therapeutic potential of deeply researched, valuable targets that are not accessible at the level of their expressed, undruggable protein.
![Logo Arrakis Therapeutics, USA](/media/hbmpartners/images/portfolio/logo/arrakis.jpg)